FDA WARNING_LETTER - Dr. Sherrill Sellman - May 27, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On June 1, 2020, the FDA and FTC issued a Warning Letter to Dr. Sherrill Sellman regarding unapproved and misbranded products related to COVID-19. The agencies reviewed websites (www.drsherrillsellman.com, archive.aweber.com/whatwomenmust, www.whatwomenmustknow.podbean.com) and social media (www.facebook.com/drsherrillsellman, www.facebook.com/whatwomenmustknow) on May 22 and May 27, 2020.
The FDA observed that "HealthMax Nano-Silver Liquid," "Silver Biotics Silver Lozenges with Vitamin C," and "Silver Biotics Silver Gel Ultimate Skin & Body Care" were offered for sale with claims to mitigate, prevent, treat, diagnose, or cure COVID-19. These products are deemed unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)).
Examples of violative claims include
ID · 8198159b-0224-44c9-b220-75b0e6913ac9
Full citation text and observation details available on the Dashboard.